News tagged ‘Leukemia’ clear
- When Charlie was diagnosed with acute lymphoblastic leukemia at age 4, his mother sent regular email updates to her large family and circle of friends. Her reflections grew into a touching chronicle of four years in the life of a child with cancer.
Tags: ChildhoodCancer, StemCellTransplant, PatientVideos, Leukemia
- Tens of thousands of childhood cancer survivors are now in their 20s, 30s, and beyond, facing life-long risks of treatment-related health issues. Increasingly, primary care physicians will need to be knowledgeable about symptoms and complaints that might be related to cancer treatments their patients received decades ago.
Tags: ChildhoodCancer, Survivorship, Leukemia
- Results suggest kinase inhibitor, teamed with chemotherapy, might reduce
the need for donor stem cell transplantation in some AML patients.
Tags: KinaseInhibitor, Leukemia
- Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.
Tags: GraftVersusHost, StemCellTransplant, Leukemia
- Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.
Tags: chemotherapy, ChildhoodCancer, Leukemia
- Dana-Farber/Boston Children's researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated in an international clinical study of a new form of gene therapy.
Tags: ChildhoodCancer, ImmuneSystem, Genetics, Leukemia
- Researchers have found several new altered genes that drive chronic lymphocitic leukemia through powerful DNA sequencing, a finding that could potentially help doctors predict whether a patient’s disease will progress rapidly or remain indolent for years.
Tags: BasicResearch, Leukemia
- Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.
Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma
- Dana-Farber investigators led a phase 1 trial in which a new oral targeted drug, idelalisib, (GS-1101), showed the potential to stave off the need for additional treatments for relapsed or treatment-resistant CLL.
- A test developed by Dana-Farber scientists is the first to identify
which malignant blood cells are highly vulnerable to a promising type of
experimental drugs that unleash pent-up cell suicide factors to destroy
Tags: BasicResearch, Leukemia